Trial Profile
Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Soft tissue infections
- Focus Pharmacokinetics
- 23 May 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 12 Aug 2011 New trial record